Epithelioid Trophoblastic Tumor Presenting as an Adnexal Mass: Report of a Diagnostically Challenging Case.


Journal

International journal of surgical pathology
ISSN: 1940-2465
Titre abrégé: Int J Surg Pathol
Pays: United States
ID NLM: 9314927

Informations de publication

Date de publication:
Aug 2023
Historique:
medline: 3 7 2023
pubmed: 11 8 2022
entrez: 10 8 2022
Statut: ppublish

Résumé

Epithelioid trophoblastic tumor (ETT) is a rare neoplasm derived from chorionic intermediate trophoblast cells, representing less than 2% of all gestational trophoblastic neoplasms. Classically, ETT presents as a uterine mass in women of reproductive age following a term pregnancy. The time from pregnancy to tumor development varies from months to several years. ETT most often arises in the endometrium, followed by the cervix. Extrauterine ETT are extremely infrequent, with few cases reported in the literature. We report a case of a 41-year-old woman, with history of three term pregnancies who presented with abdominal pain and elevated beta human chorionic gonadotropin (β-hCG) level, ten years after her last pregnancy. Imaging reported a 3.5 cm adnexal mass, suspicious for ectopic pregnancy. Hysterectomy and mass resection revealed a 4.7 cm, tan-yellow, necrotic mass adjacent to the broad ligament. Histologic evaluation in conjunction with immunohistochemical stains revealed a tumor consistent with ETT. No connection to the endometrium was found grossly or microscopically. DNA fingerprinting analysis revealed the tumor to have two copies of paternal alleles, as seen in molar gestations. One of the primary differential diagnoses for ETT is squamous cell carcinoma due to similar morphologic features. In challenging cases, genetic analysis demonstrating paternally derived genes can establish the diagnosis. In this report, we discuss the challenges in the diagnosis of extrauterine ETT, due to its rarity and highly variable presentation, given that appropriate diagnosis is critical for correct patient management.

Identifiants

pubmed: 35946122
doi: 10.1177/10668969221117983
doi:

Substances chimiques

Chorionic Gonadotropin, beta Subunit, Human 0

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

651-655

Auteurs

Julia Gallardo (J)

Department of Pathology & Immunology, Baylor College of Medicine, Houston, TX, USA.

Kelsey Hummel (K)

Department of Pathology & Immunology, Baylor College of Medicine, Houston, TX, USA.

Hanna Siatecka (H)

Department of Pathology & Immunology, Baylor College of Medicine, Houston, TX, USA.

Kristine McCluskey (K)

Department of Pathology & Immunology, Baylor College of Medicine, Houston, TX, USA.

Jan S Sunde (JS)

Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX, USA.

Abubaker Elshaikh (A)

Department of Pathology & Immunology, Baylor College of Medicine, Houston, TX, USA.

Ramya P Masand (RP)

Department of Pathology & Immunology, Baylor College of Medicine, Houston, TX, USA.
Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH